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Abstract
Background: Malaria rapid diagnostics tests (RDTs) can increase availability of laboratory-based diagnosis and
improve the overall management of febrile patients in malaria endemic areas. In preparation to scale-up RDTs in
health facilities in Malawi, an evaluation of four RDTs to help guide national-level decision-making was conducted.
Methods: A cross sectional study of four histidine rich-protein-type-2- (HRP2) based RDTs at four health centres in
Blantyre, Malawi, was undertaken to evaluate the sensitivity and specificity of RDTs, assess prescriber adherence to
RDT test results and explore operational issues regarding RDT implementation. Three RDTs were evaluated in only
one health centre each and one RDT was evaluated in two health centres. Light microscopy in a reference
laboratory was used as the gold standard.
Results: A total of 2,576 patients were included in the analysis. All of the RDTs tested had relatively high sensitivity
for detecting any parasitaemia [Bioline SD (97%), First response malaria (92%), Paracheck (91%), ICT diagnostics
(90%)], but low specificity [Bioline SD (39%), First response malaria (42%), Paracheck (68%), ICT diagnostics (54%)].
Specificity was significantly lower in patients who self-treated with an anti-malarial in the previous two weeks
(odds ratio (OR) 0.5; p-value < 0.001), patients 5-15 years old versus patients > 15 years old (OR 0.4, p-value <
0.001) and when the RDT was performed by a community health worker versus a laboratory technician (OR 0.4;
p-value < 0.001). Health workers correctly prescribed anti-malarials for patients with positive RDT results, but
ignored negative RDT results with 58% of patients with a negative RDT result treated with an anti-malarial.
Conclusions: The results of this evaluation, combined with other published data and global recommendations,
have been used to select RDTs for national scale-up. In addition, the study identified some key issues that need to
be further delineated: the low field specificity of RDTs, variable RDT performance by different cadres of health
workers and the need for a robust quality assurance system. Close monitoring of RDT scale-up will be needed to
ensure that RDTs truly improve malaria case management.
Background
In response to increasing levels of resistance to conven-
tional monotherapies, such as chloroquine, amodiaquine
and sulphadoxine-pyrimethamine, most countries in
sub-Saharan Africa have introduced artemisinin-based
combination therapy (ACT) for the treatment of
uncomplicated malaria [1]. The change in drug policy,
combined with aggressive vector control, coincides with
a decrease in malaria transmission and subsequent
decline in the proportion of fevers attributable to
malaria [2]. Although the targeting of anti-malarials only
to patients who need them has always been important,
changes in drug policy and malaria epidemiology have
increased the need for laboratory-based diagnosis of
malaria as a means to prevent the emergence of ACT
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febrile patients [3,4].
The World Health Organization (WHO) now recom-
mends malaria case management based on parasite-
based diagnosis in all cases [5]. Given the difficulty with
implementing microscopy-based definitive diagnosis of
malaria, malaria rapid diagnostic tests (RDTs) have been
suggested as an alternative [6,7]. In line with WHO
recommendations, the Malawi National Malaria Control
Programme (NMCP) has developed new malaria treat-
ment algorithms, which incorporate the use of RDTs for
definitive diagnosis of malaria in patients aged ≥5 years
who seek care in health facilities where malaria micro-
scopy is not available.
In preparation for nationwide implementation of
RDTs, the NMCP reviewed the commercially available
RDTs regarding their target antigen, sensitivity, specifi-
city, shelf-life, heat stability, cost and reliability of sup-
pliers to choose an RDT for national use. Although data
is available to inform this selection, much of it comes
from field evaluations of a single product at a time with
few studies providing head-to-head comparisons of
more than one product under operational settings
[8-13]. Since factors may vary across regions and coun-
tries, the Malawi NMCP requested locally-generated
data to aid with the selection of an RDT for national
use. Thus, four commercially available RDTs that were
being considered as potential candidates for nationwide
implementation were evaluated. The study objectives
were to assess field sensitivity and specificity, identify
factors that might affect RDT field performance, assess
prescriber adherence to RDT test results, and explore
operational issues regarding RDT implementation.
Methods
Study site
The study was conducted in Blantyre District between
January and April 2009. Blantyre is located in the south-
ern region of Malawi and has a population of 999,491
persons, the majority of whom reside in Blantyre city.
Malaria is a major public health problem in the district
with 506,029 clinically diagnosed malaria cases treated
in public health facilities in 2009, of which 57% were
aged five or more years [14]. Transmission of malaria in
the district is stable throughout the year with a peak in
the rainy season (November to March). More than 90%
of malaria infections are caused by Plasmodium falci-
parum. Access to malaria interventions in the district is
low with 43% of households owning an insecticide-trea-
ted mosquito net, and only 22% of children < 5 years of
age, who had a fever in the previous two weeks receive
treatment with an appropriate anti-malarial [15].
The district has one referral hospital and 22 public
health centres. In Blantyre city, there is a private health
sector with four large private hospitals and about 30 pri-
vate clinics. This study was conducted in one urban
(< 10 kilometers from the city centre; Bangwe), one
peri-urban (< 20 kilometres from the city centre; Chi-
leka) and two rural (≥20 km from the city centre;
Lilangwe and Mdeka) public health centres. The health
centres were selected based on the outpatient volume
(> 200 per day) and availability of clinical staff and
microscopy. Two health facilities, Bangwe and Chileka,
had microscopy for malaria diagnosis. Health centres
are staffed by different cadres of health workers: clinical
officers, medical assistants, laboratory technicians,
nurses, and community health workers. Community
health workers in Malawi, known as Health Surveillance
Assistants (HSAs), are a salaried cadre in the health sys-
tem that undergo six weeks of pre-service training. They
provide preventive and clinical services in the commu-
nity as well as assist with the delivery of preventive and
clinical services at health centres. Given the shortage of
laboratory technicians in Malawi, community health
workers have been proposed to perform RDTs in health
facilities without laboratory technicians.
Study design
A cross-sectional study design was used to assess the
performance of four histidine rich-protein-type-2
(HRP2) based RDTs: Paracheck-Pf Device (Orchid Bio-
medical Systems, India; Catalogue number 30301025),
ICT Malaria Pf Cassette Test (ICT Diagnostics, South
Africa), SD Bioline Malaria Antigen P.f (Standard Diag-
nostics, Korea; Catalogue number 05FK50) and First
Response Malaria (HRP2) Antigen (Premier Medical,
India; Catalogue number I13FRC30). Each RDT was
evaluated at only one health centre except Paracheck-Pf,
which was evaluated at two health centres.
Study procedures
Training of health workers
All health workers underwent cadre-specific training.
Clinicians and nurses had one-day refresher training on
malaria diagnosis and treatment based on the new
national malaria treatment guidelines. During this train-
ing, the diagnosis and treatment of malaria patients
using an algorithm which included the use of RDTs was
reviewed. In sites with microscopy, health workers were
instructed to treat patients according to local micro-
scopy results. In the two sites without microscopy,
health workers were instructed to treat patients accord-
ing to RDT results.
Laboratory technicians from the two health facilities
with microscopy underwent refresher training on
malaria microscopy. Community health workers from
the facilities without microscopy services received three-
day training on blood sample collection via a finger
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laboratory technicians and community health workers
received training on how to use all four RDTs according
to manufacturer’s instructions. In addition, job aids that
contained information on criteria for study eligibility,
RDT-based treatment algorithm, instructions on how to
prepare and interpret RDTs according to a modified
version of the generic WHO job aid were provided to
all health workers [16].
Enrollment of participants, data collection and patient
protection
Eligible participants were consecutively enrolled in the
outpatient departments of the selected health centres.
Inclusion criteria were age ≥5 years, a documented fever
or a history of fever in the previous 24 hours and con-
sent to participate in the study. Pregnant women and
patients with severe illness were excluded from the
study.
Clinicians and nurses enrolled study participants and
collected demographic and clinical information using a
structured form. Completed forms were collected once
weekly from the study sites. At the time of collection,
forms were checked for completeness and consistency of
recorded information and where possible, missing data
and discrepancies were corrected on site in consultation
with the health worker who had completed the form.
Patient flow through the study is presented in Figure 1.
Malaria diagnosis
An RDT was conducted on all enrolled patients using
whole blood collected via a finger prick. The reading
and interpretation of results were based on the specific
instructions provided by the RDT manufacturer in the
Assess for eligibility
Non-pregnant persons >5 years old with documented fever 
or a history of fever in the previous 24 hours
Obtain informed consent
Complete recruitment form
Health centers with laboratory
Laboratory technician performs malaria 
rapid diagnostic test and microscopy 
Health centers without laboratory
Community health worker performs
malaria rapid diagnostic test and collects
blood slide to be read later
Prescriber
Laboratory test results available to make decisions about 
prescribing antimalarials
Pharmacy
Antimalarials dispensed from pharmacy
Figure 1 Flow of patients in malaria rapid diagnostic test study.
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from the same finger prick blood sample and air-dried
by laboratory staff. In the two health centres with
microscopy, the slides were stained with Field’sS t a i nA
and B (azure dye and eosin) by the local laboratory
technician and read locally before being sent to a central
laboratory at the College of Medicine once a week.
Slides from the two health centres without microscopy
were sent directly to the central laboratory where they
were stained with Field’sS t a i nAa n dBb ya ne x p e r t
microscopist. At the central laboratory all slides were
independently read by two expert microscopists. Discor-
dant results on presence or absence of parasitaemia
between the two expert microscopists were resolved by
referring to a third expert microscopist. All laboratory
staff reading microscopy slides both locally and at the
central laboratory were blinded to RDT and other
microscopy results. A blood slide was considered nega-
tive if no trophozoites were seen after examining 100
high power fields (100 × objective)[17]. Malaria parasite
count per microlitre of blood from the thick film was
estimated by multiplying the average number of para-
sites per high power field by 500 [17]. Gametocytes
were not counted.
Sample size and power
To estimate 90% RDT sensitivity compared to expert
microscopy with 80% power and 95% confidence inter-
val of ± 5%, 138 patients with parasitaemia by expert
microscopy were required [18]. Assuming a slide posi-
tivity rate of 40% in patients more than five years of age
presenting with fever and adjusting for at least 10% for
refusals we set out to recruit a minimum of 384 febrile
patients per RDT.
Data analysis
The primary outcome measures were RDT sensitivity and
specificity using microscopy as a gold standard. In addi-
tion, we assessed prescriber adherence to RDT test
results. Data was double entered in SPSS version 12.0
(SPSS Inc., Chicago, Illinois, USA) and analyzed using
STATA version 10 (StataCorp, College Station, Texas,
USA) and SAS version 9.2 (SAS Institute, Cary, NC,
USA). Chi square statistics were used to compare differ-
ences between persons tested with the different RDTs.
Due to confounding between RDT type and health centre
characteristics, such as the cadre of health worker who
performed the RDT, two different logistic regression
models were used to assess the effects of RDT type and
RDT operator (e.g. cadre of health worker performing
the RDT) on RDT sensitivity and specificity. Model 1
assessed the variables: RDT type, measured temperature
(≥37.5°C vs. < 37.5°C), geometric mean parasite density
(≥5000 asexual parasites per microlitre vs. < 5000 asexual
parasites per microlitre), and history of self-treatment
with anti-malarials in the last two weeks. Model 2
assessed the variables: measured temperature (≥37.5°C vs.
< 37.5°C), geometric mean parasite density (≥5000 asex-
ual parasites per microlitre vs. < 5000 asexual parasites
per microlitre), history of self-treatment with anti-malar-
ials in the last two weeks, and cadre of health worker per-
forming the RDT (community health worker versus
laboratory technician). An assessment of RDT type and
RDT operator could not be done in a unified multivari-
able logistic regression model due to confounding.
Ethical approval
This study was approved by the Malawi College of Med-
icine ethical committee and the United States Centers
for Disease Control and Prevention Institutional Review
Board.
Results
A total of 2,679 patients were recruited, but only 2,573
(96%) patients with complete RDT and expert micro-
scopy results were included in the analysis. Demo-
graphic characteristics varied significantly between
persons tested with the different RDTs (Table 1).
Malaria prevalence varied significantly at the different
RDT testing sites (p < 0.001); the prevalence of micro-
scopically confirmed malaria increased from urban to
semi-urban and to rural settings: 3%, 16% and 39%
respectively. Overall reported self-treatment with anti-
malarials was 12%, but this varied significantly among
the different RDT testing sites with a range of 5% in
Lilangwe and 29% in Chileka (p < 0.001).
Sensitivity and specificity of malaria rapid diagnostic tests
SD Bioline Malaria Antigen P.f had the highest sensitiv-
ity at 97% followed by First Response Malaria (HRP2)
Antigen at 92% (Table 2). The overall sensitivity of Para-
check-Pf was 90% but this varied by site with a sensitiv-
ity of 96% (185/201) in Mdeka and only 59% (10/17) in
Bangwe with the Bangwe results based on relatively few
samples. Using a logistic regression model adjusting for
age group (5-15 years vs. > 15 years), measured tem-
perature (≥ 37.5°C vs. < 37.5°C), geometric mean para-
site density (≥ 5,000 asexual parasites per microlitre vs.
< 5,000 asexual parasites per microlitre), and history of
self treatment with anti-malarials in the last two weeks,
none of the RDTs tested were significantly more sensi-
tive than ICT Malaria Pf (Table 2).
Overall, there were 44/633 (7%) false negative RDT
results (RDT negative, gold standard microscopy posi-
tive). Of the 44 patients that had false negative RDT
results, four (9%) had an asexual parasite density of
< 200 parasites per microlitre, 4 (9%) had an asexual
parasite density of 200-499 parasites per microlitre, 10
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microlitre and 26 (59%) had a density of > 5,000 para-
sites per microlitre.
All of the RDTs tested had low specificity ranging
from 39% for SD Bioline Malaria Antigen P.f to 68% for
Paracheck-Pf (Table 3). Using a logistic regression
model adjusting for age group (5-15 years vs. > 15
years), measured temperature (≥37.5°C vs. < 37.5°C),
and history of self-treatment with anti-malarials in the
last two weeks, SD Bioline Malaria Antigen P.f and First
Response Malaria (HRP2) Antigen had significantly
lower specificity than ICT Malaria P.f, while Paracheck-
Pf had significantly higher specificity than ICT Malaria
P.f (Table 3).
In comparison to the field performance of RDTs, the
sensitivity and specificity of local microscopy were 88%
(15/17) and 74% (401/544) in Bangwe, 91% (99/109) and
36% (204/574) in Chileka, 91% (114/126) and 54% (605/
1128) in both sites combined, respectively.
Predictors of malaria rapid diagnostic test performance
Given the relatively high sensitivity, but coupled with
low specificity of all RDTs tested, potential factors for
this phenomenon were explored. Given the design of
this study where any RDT was only performed by either
a community health worker or a laboratory technician,
it was not possible to ascertain whether the measured
sensitivity and specificity was due to the properties of
the test (RDT itself) or the test operator (community
health worker versus laboratory technician). However,
using a logistic regression model adjusting for age group
(5-15 years vs. > 15 years), measured temperature
(≥37.5°C vs. < 37.5°C), and history of self-treatment with
anti-malarials in the last two weeks, it was found that
for all RDTs the sensitivity was significantly higher (p =
0.02) and the specificity significantly lower (p < 0.001)
when the RDTs were performed by community health
workers compared to laboratory technicians (Tables 2
and 3).
In addition, the sensitivity was significantly higher and
the specificity significantly lower in patients 5-15 years
old compared to patients > 15 years, even after adjusting
for other potential confounders such as RDT type, mea-
sured temperature (≥37.5°C vs. 37.5°C), and history of
self-treatment with anti-malarials in the last two weeks.
Lastly, history of self-treatment with anti-malarials in
the last two weeks was associated with lower specificity
(Table 3). Geometric parasite density was not found to
be significantly associated with RDT sensitivity in either
the univariate or multivariate models.
Health worker adherence to malaria diagnostic test
results and training instructions
Health workers adhered to microscopy and RDT posi-
tive results and prescribed anti-malarials for over 98% of
patients who had positive test results (Table 4). Of note,
Table 1 Health facility and patient characteristics in malaria rapid diagnostic test (RDT) evaluation in Blantyre, Malawi,
2009
RDT name Bioline SD First response
malaria
ICT diagnostics Paracheck Total P value*
Health centre name Mdeka
(N = 476)
Lilangwe
(N = 508)
Chileka
(N = 683)
Bangwe
(N = 573)
Mdeka
(N = 333)
(N = 2,573)
Health facility characteristics
Location Rural Rural Semi-urban Urban Rural
Person performing RDT CHW
‡ CHW
‡ Laboratory
Technician
Laboratory
Technician
CHW
‡
Patient characteristics
Female 59% 60% 59% 56% 65% 59% 0.13
Child 5-15 years old 44% 56% 37% 36% 30% 42% < 0.001
Owns a mosquito net
Used a mosquito net the
previous night
54%
50%
62%
63%
51%
48%
43%
41%
58%
61%
53%
52%
< 0.001
< 0.001
Self treated with antimalarial in
past 2 weeks
8% 5% 29% 8% 2% 12% < 0.001
Presumptive malaria diagnosis 100% 99% 27% 92% 100% 89% < 0.001
Local microscopy positive
† na na 69% 29% na 51% < 0.001
RDT positive 76% 72% 53% 25% 66% 56% < 0.001
Expert microscopy positive 41% 40% 16% 3% 34% 25% < 0.001
* Statistical testing using chi square test for trend
† Local microscopy available only in Chileka and Bangwe Health Centres
‡ CHW = Community health worker
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Page 5 of 9Table 2 Predictors of malaria rapid diagnostic test (RDT) sensitivity (RDT positive, expert microscopy positive) in
Blantyre, Malawi, 2009
Sensitivity
n/N(%)
Unadjusted odds
ratio
(P value)
Adjusted odd ratio
Model 1
(P value)
Adjusted odds ratio
Model 2
(P value)
RDT type
Bioline SD 188/193 (97) 2.6 (0.17) 2.9 (0.14)
First response malaria 185/201 (92) 1.1 (0.82) 1.1 (0.84)
Paracheck 118/130 (91) 0.8 (0.63) 0.8 (0.77)
ICT diagnostics 98/109 (90) Referent Referent
Age
5t o≤ 15 yrs 369/382 (97) 4.8 (< 0.001) 5.1 (< 0.001) 5.1 (< 0.001)
> 15 yrs 206/237 (87) Referent Referent Referent
Temperature
≥ 37.5°C 281/298 (94) 2.1 (0.09) 1.7 (0.23) 1.7 (0.22)
< 37.5°C 286/310 (92) Referent Referent Referent
Geometric mean parasite density
≥ 5000 per μl 181/193 (94) 1.1 (0.74) 0.7 (0.36) 0.6 (0.32)
< 5000 per μl 408/440 (93) Referent Referent Referent
Self-treated with antimalarial in past 2
weeks
Yes 44/51 (86) 0.9 (0.85) 1.2 (0.82) 2.1 (0.38)
No 501/538 (93) Referent Referent Referent
RDT performed by:
Community health worker 481/507 (95) 2.6 (0.03) 3.1 (0.02)
Laboratory technician 108/126 (86) Referent Referent
Model 1 assesses RDT type adjusted for patient age, temperature, parasite density, and self-treatment with anti-malarials.
Model 2 assesses RDT test operator (community health worker versus laboratory technician) adjusted for patient age, temperature, parasite density, and self-
treatment with anti-malarials.
Table 3 Predictors of malaria rapid diagnostic test (RDT) specificity (RDT negative, expert microscopy negative) in
Blantyre, Malawi, 2009
Specificity
n/N(%)
Unadjusted odds ratio
(P value)
Adjusted odd ratio
Model 1
(P value)
Adjusted odds ratio
Model 2
(P value)
RDT type
Bioline SD 109/283 (39) 0.5 (< 0.001) 0.5 (< 0.001)
First response malaria 128/307 (42) 0.6 (< 0.001) 0.7 (0.01)
Paracheck 530/776 (68) 1.8 (< 0.001) 2.1 (< 0.001)
ICT diagnostics 311/574 (54) Referent Referent
Age
5t o≤ 15 yrs 278/680 (41) 0.4 (< 0.001) 0.4 (< 0.001) 0.4 (< 0.001)
> 15 yrs 778/1211 (64) Referent Referent Referent
Temperature
≥37.5°C 422/790 (53) 0.8 (0.03) 0.8 (0.02) 0.9 (0.20)
< 37.5°C 640/1092 (59) Referent Referent Referent
Self-treated with antimalarial in past 2 weeks
Yes 126/254 (50) 0.7 (0.02) 0.7 (0.05) 0.5 (< 0.001)
No 920/1605 (57) Referent Referent Referent
RDT performed by:
Community health worker 346/810 (43) 0.4 (< 0.001) 0.4 (< 0.001)
Laboratory technician 732/1130 (65) Referent Referent
Model 1 assesses RDT type adjusted for patient age, temperature and self-treatment with anti-malarials.
Model 2 assesses RDT test operator (community health worker versus laboratory technician) RDT test operator adjusted for patient age, temperature and self-
treatment with anti-malarials.
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patients with discordant results (microscopy positive
a n dR D Tn e g a t i v e )a c c o r d i ng to training. However,
health workers rarely withheld treatment, even in the
setting of negative test results; 58% of patients with a
negative RDT result were still treated with an anti-
malarial despite our training. Only 7% of patients who
were both microscopy-negative and RDT-negative were
prescribed an anti-malarial.
Discussion
Decreasing malaria transmission leading to a decline in the
proportion of fevers attributable to malaria in sub-Saharan
Africa and the use of relatively expensive first-line anti-
malarials have increased the importance of accurate
malaria diagnosis at all levels of the health system [2].
Malaria RDTs must have both high (> 95%) sensitivity and
specificity in field settings. High sensitivity is necessary to
ensure that true cases of malaria are detected and appro-
priately managed while high specificity is needed to avoid
false positive results that would lead not only to unneces-
sary anti-malarial treatment but also a missed diagnosis of
the true cause of non-malarial fever.
The sensitivity of the RDTs evaluated in this study are
similar to the results of other published studies [8-12].
Surprisingly, all of the RDTs evaluated had relatively
low specificity resulting in high false positive rates com-
pared to most published studies [8-13]. Only a few stu-
dies have reported low specificity [19,20]. Both
biological and operational factors that could have
resulted in low specificity in this study were explored.
HRP2 is known to persist in the blood stream for sev-
eral weeks and some loss of specificity might be due to
patients with circulating antigens, but not live parasites
that would be detected by microscopy [20]. In this
study, 12% of patients had self-treated with anti-malar-
ials prior to presenting for care to the health facility and
might have cleared their parasitaemia, but have residual
circulating antigens. The analysis shows that even after
adjusting for other factors, self-treatment was signifi-
cantly associated with lower specificity.
However, even after adjusting for self-treatment with
anti-malarials in the past two weeks, two other factors
that do not have a plausible biological explanation were
independently associated with low specificity: being a
patient 5-15 years of age and having the test performed
by a community health worker. It is unclear why specifi-
city was lower in patients 5-15 years of age. However, it
is possible that health workers interpreting RDTs were
more likely to err on the side of caution and interpret
questionable test results as positive resulting in reduced
specificity. In particular, the specificity was significantly
lower when the RDT was performed by a community
health worker compared to a laboratory technician. This
demonstrates that despite their relative ease of use, the
accuracy of RDT results is affected by the cadre of the
person performing them. This finding has important
implications for training and decisions about which
cadre of staff are selected for performing the tests.
Access to malaria diagnosis in rural areas is essential for
promoting rational clinical care and community health
workers have been shown to reliably perform RDTs in
other settings [21]. However it is vital that health work-
ers base their clinical decisions on accurate diagnostic
test results. Training, certification and supervision of
community health workers on RDT use, should there-
fore be rigorous enough to ensure the reliability and
validity RDT test results in field settings. In addition,
the specificity is also relatively low (54%) for routine
microscopy at the health facilities in this study. The low
specificity of both RDTs and microscopy is concerning
because it can potentially misguide clinicians, compro-
mise the cost effectiveness of RDTs, and might contri-
bute to the emergence of drug resistance [22-25]. More
research needs to be done to further explore this phe-
nomenon, especially in light of upcoming plans to
implement RDTs in health facilities in Malawi. This eva-
luation highlights critical areas for operational research,
including who should perform RDTs and how to moni-
tor RDT performance in health facilities.
Over-diagnosis of malaria, involving provision of anti-
malarial drugs to patients without evidence of
Table 4 Health worker adherence to malaria diagnostic test results and training instructions in Blantyre, Malawi, 2009
Test results Training instructions Treated with anti-malarial
n/N (%)
Sites with local microscopy
Microscopy positive, RDT positive Treat for malaria 366/368 (99)
Microscopy positive, RDT negative Treat for malaria 283/286 (99)
Microscopy negative, RDT negative Do not treat for malaria 34/471 (7)
Microscopy negative, RDT positive Do not treat for malaria 83/155 (54)
Sites without local microscopy
RDT positive Treat for malaria 985/1,005 (98)
RDT negative Do not treat for malaria 223/385 (58)
RDT = Malaria rapid diagnostic test
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ments the magnitude of this problem in Blantyre,
Malawi [26-30]. In Malawi, for a considerable period of
time, all fevers have been assumed to be malaria. Health
education messages have stressed the importance of
treating malaria and few diagnostic facilities have been
available to support other diagnoses. It is unsurprising,
therefore, that over half of all negative test results in
this study were disregarded. Nonetheless, this observa-
tion serves to highlight that roll out of RDTs should be
accompanied by comprehensive package for health
workers. This should include not only in-service training
emphasizing the need to target malaria treatment to
patients with laboratory-confirmed parasitaemia, but
also provide alternative treatment for patients with
negative malaria diagnostics tests results who have
another cause for their febrile illness. Improvement of
overall management of febrile patients in remote areas
will have to promote use of diagnostic tools for both
malaria and other febrile illnesses [31]. Although diffi-
cult to interpret since most health workers in routine
practice will not have access to both microscopy and
RDT results, health workers rarely treated patients with
anti-malarials when both microscopy and RDT were
negative. Further research into why health workers dis-
regard malaria diagnostic test results is needed given the
substantial resources that will be put into RDT scale-up.
Limitations
Different cadres of health care workers (clinical officers,
medical assistants, nurses, community health workers)
were involved in the study for both patient recruitment
and treatment. The staff mix in the study sites was not
uniform. In general health workers in facilities with
microscopy were higher ranking than those in remote
facilities without microscopy. Abilities to competently
manage febrile patients in the sites were, therefore,
inherently different. This may have affected degree of
adherence to study procedures, RDT manufacturer’s
instructions, the quality of information collected and
ultimately the performance of the RDT tests. In particu-
lar, a key limitation of the study was the confounding of
RDT type and the health worker cadre who was per-
forming the test (community health worker versus
laboratory technician). Although, it was attempted to
assess the importance of these two factors on RDT per-
formance by using different multivariable models, it was
not possible to fully assess the effects of the test versus
the test operator in a single unified model.
Although this was a pilot study used to help guide
policy development in Malawi regarding the choice of
RDT, other factors such as heat stability, lot-to-lot varia-
tion, and ease of use, which would influence the even-
tual choice of RDT for national policy were not tested.
Neither was an evaluation of other practical considera-
tions for country programmes, such as the relative cost
of different RDTs and manufacturing capacity of suppli-
ers carried out. Although over 2,500 patients were
assessed, the results of this study are meant to be sup-
plementary to other more detailed evaluations, such as
the World Health Organization report entitled “Malaria
Rapid Diagnostic Test Performance Results of WHO
product testing of malaria RDTs: Round 2 (2009)” [6,7].
Conclusions
This evaluation was designed to provide local data for
decision making by the Malawi National Malaria Control
Programme regarding the scale-up of RDTs in Malawi.
The results of this evaluation, combined with other pub-
lished data and the World Health Organization product
testing of malaria RDTs, have been used to help select
RDTs for national scale-up [6]. This pilot exercise has
highlighted some key issues that need further exploration
as Malawi proceeds with RDT scale-up. The low specifi-
city of both RDTs and routine microscopy needs to be
further delineated. In addition, operational research on
strategies to monitor RDT performance and develop a
r o b u s tq u a l i t ya s s u r a n c es y s tem is needed. Lastly, the
question of variable RDT performance by different cadres
of health workers has to be addressed. Malawi is embark-
ing on rapid scale-up of RDTs in health facilities with the
goal of universal diagnosis of all persons more than five
years of age. Close monitoring will be needed to ensure
that RDTs truly improve malaria case management.
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